Login | Register

Melanoma patients may benefit from new biomarker

Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *